Delivery Order SPE2DX22D0040-SPE2D826FA3KH
- Not listed
- On January 6, 2026, the Defense Logistics Agency's Medical Supply Chain awarded a $3,312 delivery order (contract number 4570413314) to AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc. This firm fixed-price contract is scheduled for completion by January 7, 2026 and will be performed in Conshohocken, Pennsylvania. The award was made on a non-set-aside, competitive basis and represents a task order issued under AmerisourceBergen's existing $1 billion Indefinite Delivery Contract with...
- On January 7, 2026, the Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $34,835.16 to Amerisourcebergen Drug Corp (CAGE 0U9U0), a subsidiary of Cencora, Inc. This firm fixed-price delivery order is scheduled for completion by January 8, 2026, with performance taking place at the contractor's Conshohocken, Pennsylvania facility. The award was made on a competitive, non-set-aside basis and represents a task order issued under a larger vehicle supporting federal...
- On January 8, 2026, the Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $2,385.42 to AmerisourceBergen Drug Corp (CAGE 0U9U0), a subsidiary of parent company Cencora, Inc. This firm fixed-price delivery order, with an ultimate completion date of January 9, 2026, represents a competitively awarded, non-set-aside contract supporting federal medical procurement needs. The work will be performed at the awardee's Corporate Office location in Conshohocken,...
- On January 6, 2026, the Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $33,110.10 to AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., headquartered in Conshohocken, Pennsylvania. This firm fixed-price delivery order, designated as contract number 4570405466, carries an ultimate completion date of January 7, 2026 and represents a non-set-aside award issued through open competition. The work will be performed at the awardee's corporate office location...
- Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., was awarded a delivery order valued at $34,593.82 on January 7, 2026, by the Defense Logistics Agency's Medical Supply Chain. This firm fixed-price, non-set-aside contract is scheduled for completion by January 8, 2026, with performance taking place at the contractor's corporate office in Conshohocken, Pennsylvania. The delivery order represents a task order under Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with DLA...
- AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., was awarded a delivery order valued at $1,144.41 on January 6, 2026, by the Defense Logistics Agency's Medical Supply Chain, with an ultimate completion date of January 7, 2026. This firm fixed-price delivery order represents a child contract under a larger indefinite delivery vehicle and was competitively awarded without set-aside designation. The work will be performed at the awardee's corporate office location in Conshohocken,...
- Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., was awarded a delivery order on January 7, 2026, valued at $21,483.00 under a firm fixed-price contract with the Defense Logistics Agency's Medical Supply Chain. This non-set-aside award is scheduled for completion by January 8, 2026, with performance occurring at the company's corporate office in Conshohocken, Pennsylvania. The delivery order represents a task order execution under Amerisourcebergen's larger Indefinite Delivery...
- Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., was awarded a delivery order valued at $31,173.60 by the Defense Logistics Agency's Medical Supply Chain on January 6, 2026, with an ultimate completion date of January 7, 2026. This firm fixed-price contract was competitively awarded with no set-aside designation and will be performed at the company's Corporate Office location in Conshohocken, Pennsylvania. The delivery order represents a task order issued under Amerisourcebergen's...
- Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., was awarded a delivery order valued at $30,977.72 on January 7, 2026, by the Defense Logistics Agency's Medical Supply Chain. This firm fixed-price, non-set-aside contract has a completion date of January 8, 2026, with performance taking place at the company's corporate office in Conshohocken, Pennsylvania. The delivery order represents a task order issued under Amerisourcebergen's larger Indefinite Delivery Contract with DLA Troop...
- Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., was awarded a delivery order valued at $93,276.40 on January 7, 2026, by the Defense Logistics Agency's Medical Supply Chain. The contract, designated as a firm fixed-price delivery order with no set-aside, will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of January 8, 2026. This delivery order is issued under Amerisourcebergen's larger Indefinite Delivery...
- SPE2DX22D0040Indefinite Delivery Contract
- SPE2DX22D0040-SPE2D826FA3KHDelivery Order
On January 8, 2026, the Defense Logistics Agency's Medical Supply Chain awarded a $34,694 firm fixed-price delivery order (Contract No. 4570434585) to AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc. This non-competitive delivery order is scheduled for ultimate completion by January 9, 2026, with performance taking place at the awardee's corporate office in Conshohocken, Pennsylvania. The delivery order represents a task order issued under a larger Indefinite Delivery Contract vehicle—the DLA Troop Support Medical IDC valued at up to $999,999,999.00 through December 2026—which serves as a comprehensive global pharmaceutical support mechanism enabling AmerisourceBergen to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. AmerisourceBergen's federal contract portfolio demonstrates significant capability in delivering diverse pharmaceutical commodities across multiple therapeutic domains, including specialty medications, brand-name and generic drugs, vaccines, medical devices, and specialized healthcare supplies. The parent company, Cencora, Inc., maintains an extended IDC with the DLA Troop Support Medical valued at up to $999,999,999.00 through December 31, 2031, underscoring the company's critical role in the federal pharmaceutical supply chain. This delivery order supports the Defense Health Agency and broader military healthcare operations, reflecting the ongoing demand for reliable pharmaceutical distribution to support troops and veterans' healthcare systems globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $34.7k | 1/7/26 |